ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,626.63
-0.14%
US Tech 100
19,048.40
-0.79%
Dow Jones
41,263.37
0.21%
Brent Oil
80.065
2.16%
Bitcoin
63,785.91
-0.89%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aileron Therapeutics Inc (ALRN)

  7. Aileron Therapeutics Inc (ALRN) News

ALRN

Aileron Therapeutics (ALRN)

Aileron Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALRN
DateTimeSourceHeadlineSymbolCompany
08/22/20244:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
08/22/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
08/22/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
08/21/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
08/19/20244:05PMPR Newswire (US)Aileron Therapeutics to Present at the 8th Annual IPF SummitNASDAQ:ALRNAileron Therapeutics Inc
08/14/20246:05PMPR Newswire (US)Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business HighlightsNASDAQ:ALRNAileron Therapeutics Inc
08/14/20245:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
08/14/20245:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALRNAileron Therapeutics Inc
07/30/20248:00AMPR Newswire (US)Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:ALRNAileron Therapeutics Inc
07/26/20244:36PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
07/26/20244:33PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALRNAileron Therapeutics Inc
07/26/20244:29PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ALRNAileron Therapeutics Inc
07/09/20248:41AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ALRNAileron Therapeutics Inc
07/09/20248:36AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ALRNAileron Therapeutics Inc
07/09/20248:30AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALRNAileron Therapeutics Inc
07/01/20248:00AMPR Newswire (US)Aileron Therapeutics to be Included in the Russell Microcap® IndexNASDAQ:ALRNAileron Therapeutics Inc
06/05/20246:58AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
05/16/20245:19PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
05/16/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
05/15/20245:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
05/15/20245:13PMGlobeNewswire Inc.Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:ALRNAileron Therapeutics Inc
05/15/20245:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALRNAileron Therapeutics Inc
05/06/20244:05PMGlobeNewswire Inc.Aileron Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:ALRNAileron Therapeutics Inc
05/03/20244:05PMGlobeNewswire Inc.Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 MillionNASDAQ:ALRNAileron Therapeutics Inc
05/01/20248:45AMGlobeNewswire Inc.Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 MillionNASDAQ:ALRNAileron Therapeutics Inc
05/01/20248:30AMGlobeNewswire Inc.Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:ALRNAileron Therapeutics Inc
04/15/20245:20PMGlobeNewswire Inc.Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ALRNAileron Therapeutics Inc
03/12/20248:00AMGlobeNewswire Inc.Aileron Therapeutics Announces CEO TransitionNASDAQ:ALRNAileron Therapeutics Inc
03/06/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALRNAileron Therapeutics Inc
02/29/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALRNAileron Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ALRN

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
MONI
Moon Equity (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
NVDA
NVIDIA
USOTC
ABQQ
AB (PK)
NASDAQ
MULN
Mullen Automotive
USOTC
SINC
Sincerity Applied Materi... (PK)
COIN
XRPUSD
Ripple
NASDAQ
COOP
Mr Cooper
USOTC
XERI
Xeriant (QB)
USOTC
WDLF
Decentral Life (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
FNMA
Fannie Mae (QB)
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved